An open-label trial in 2050 elderly outpatients with depression treated with escitalopram in a naturalistic setting in Germany

被引：0
|
作者：
Moeller, H.-J. [1 ]
Schnitker, J. [2 ]
Fluerenbrock, W. [3 ]
Fuger, J. [4 ]
机构：
[1] Univ Munich, Dept Psychiat, D-8000 Munich, Germany
[2] Inst Angew Stat GmbH, Bielefeld, Germany
[3] Lundbeck GmbH, Sci Unit, Hamburg, Germany
[4] Lundbeck GmbH, Med Affairs, Hamburg, Germany
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [31] Psychiataric symptoms among outpatients in an open-label trial of risperidone for methamphetamine dependence
    Jaffe, C
    Saxon, AJ
    Meredith, CW
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S146 - S146
  • [32] Escitalopram for perimenopausal depression: An open-label pilot study (vol 15, pg 857, 2006)
    Freeman, M. P.
    Hill, R.
    Brumbach, B. H.
    JOURNAL OF WOMENS HEALTH, 2006, 15 (08) : 988 - 988
  • [33] ESCITALOPRAM AND MIRTAZAPINE FOR THE TREATMENT OF DEPRESSION IN HIV PATIENTS: A RANDOMIZED CONTROLLED OPEN LABEL TRIAL
    Patel, Shanti
    Kukreja, Sanjay
    Atram, Umesh
    De Sousa, Avinash
    Shah, Nilesh
    Yadav, Sameer
    Sonavane, Sushma
    ASEAN JOURNAL OF PSYCHIATRY, 2013, 14 (01): : 31 - 39
  • [34] Escitalopram for major depression in Parkinson's disease: An open-label, flexible-dosage study
    Weintraub, Daniel
    Taraborelli, Donna
    Morales, Knashawn H.
    Duda, John E.
    Katz, Ira R.
    Stern, Matthew B.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 18 (03) : 377 - 383
  • [35] EVALUATION OF rTMS TREATMENT OUTCOMES: COMPARING TREATMENT PROTOCOL AND DOSING IN AN OPEN-LABEL NATURALISTIC SETTING
    Lax, M.
    Boros-Lavack, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (01): : 150 - 151
  • [36] BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) LEVELS IN DEPRESSED WOMEN TREATED WITH OPEN-LABEL ESCITALOPRAM
    Ladea, Maria
    Bran, Mihai
    PSYCHIATRIA DANUBINA, 2013, 25 (02) : 128 - 132
  • [37] An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients
    Ersoy, Mehmet A.
    Noyan, Aysin M.
    Elbi, Hayriye
    CLINICAL DRUG INVESTIGATION, 2008, 28 (02) : 113 - 120
  • [38] An open-label trial of citalopram for major depression in patients with hepatitis C
    Gleason, OC
    Yates, WR
    Isbell, MD
    Philipsen, MA
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (03) : 194 - 198
  • [39] Comparative Analysis of the Effects of Escitalopram, Pramipexole, and Transcranial Magnetic Stimulation on Depression in Patients With Parkinson Disease: An Open-Label Randomized Controlled Trial
    Chen, Jing
    Xu, Pengfei
    Guo, Xunyi
    Zou, Tao
    CLINICAL NEUROPHARMACOLOGY, 2022, 45 (04) : 84 - 88
  • [40] Mirtazapine in Comorbid Major Depression and Alcohol Dependence: An Open-Label Trial
    Cornelius, Jack R.
    Douaihy, Antoine B.
    Clark, Duncan B.
    Chung, Tammy
    Wood, D. Scott
    Daley, Dennis
    JOURNAL OF DUAL DIAGNOSIS, 2012, 8 (03) : 200 - 204
12345